Literature DB >> 12221707

In vivo evaluation of hydroxyapatite foams.

P Sepulveda1, A H Bressiani, J C Bressiani, L Meseguer, B König.   

Abstract

Hydroxyapatite (HA) is widely applied as bone graft material due to its osteoconductive potential and well-established biocompatibility. In this work, macroporous hydroxyapatite structures made through foaming of aqueous suspensions and gelcasting were tested for in vivo osteointegration. These foams are composed of a three-dimensional array of spherical pores with diameters of approximately 100-500 microm, interconnected by windows of smaller size in the range of 30-120 microm. The HA foams were implanted in the tibia of albino New Zealand rabbits and removed after a period of 8 weeks. Histological analysis revealed that the pores in the foams were partially or completely filled progressively with mature new bone tissue and osteoid after the implanted period. No immune or inflammatory reactions were detected. The high osteoconductive potential of the HA foams provides a potential structure for use as bone substitute in orthopedic, oral, and cranio-maxillofacial reconstructive surgery, and as dento-alveolar implants. Copyright 2002 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12221707     DOI: 10.1002/jbm.10173

Source DB:  PubMed          Journal:  J Biomed Mater Res        ISSN: 0021-9304


  5 in total

1.  Substituted hydroxyapatites for bone repair.

Authors:  Jennifer H Shepherd; David V Shepherd; Serena M Best
Journal:  J Mater Sci Mater Med       Date:  2012-03-03       Impact factor: 3.896

2.  Microstructural and in vitro characterization of SiO2-Na2O-CaO-MgO glass-ceramic bioactive scaffolds for bone substitutes.

Authors:  C Vitale-Brovarone; E Vernè; M Bosetti; P Appendino; M Cannas
Journal:  J Mater Sci Mater Med       Date:  2005-10       Impact factor: 3.896

3.  Macroporous bioactive glass-ceramic scaffolds for tissue engineering.

Authors:  C Vitale Brovarone; E Verné; P Appendino
Journal:  J Mater Sci Mater Med       Date:  2006-11-22       Impact factor: 3.896

4.  SBA-15 ordered mesoporous silica inside a bioactive glass-ceramic scaffold for local drug delivery.

Authors:  V Cauda; S Fiorilli; B Onida; E Vernè; C Vitale Brovarone; D Viterbo; G Croce; M Milanesio; E Garrone
Journal:  J Mater Sci Mater Med       Date:  2008-05-22       Impact factor: 3.896

5.  Bacterial cellulose membrane functionalized with hydroxiapatite and anti-bone morphogenetic protein 2: A promising material for bone regeneration.

Authors:  Fernanda Coelho; Maurício Cavicchioli; Sybele Saska Specian; Raquel Mantuaneli Scarel-Caminaga; Letícia de Aquino Penteado; Alexandra Ivo de Medeiros; Sidney José de Lima Ribeiro; Ticiana Sidorenko de Oliveira Capote
Journal:  PLoS One       Date:  2019-08-19       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.